Home > Cashflow Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
AD     Remove this Ad

PIRAMAL PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹892 Cr₹1,005 Cr₹484 Cr₹766 Cr₹598 Cr

What is the latest Cash Flow from Operating Activities ratio of PIRAMAL PHARMA ?

The latest Cash Flow from Operating Activities ratio of PIRAMAL PHARMA is ₹892 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹892 Cr
Mar2024₹1,005 Cr
Mar2023₹484 Cr
Mar2022₹766 Cr
Mar2021₹598 Cr

How is Cash Flow from Operating Activities of PIRAMAL PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹892 Cr
-11.17
Mar2024 ₹1,005 Cr
107.60
Mar2023 ₹484 Cr
-36.86
Mar2022 ₹766 Cr
28.25
Mar2021 ₹598 Cr -

Compare Cash Flow from Operating Activities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹20,755.5 Cr -3.7% 1% -22.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-3.7%

1%

-22.3%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses